Revitope Oncology
Mark has nearly 30 years’ of experience in Biotechnology companies as a CBO, CFO and COO, leading private and public companies within Europe and the US. Mark has grown a number of companies from start up through IPO and trade sale, and has additional, extensive experience structuring and managing successful deals with world leading Pharmaceutical and Biopharmaceutical companies. He is a Chartered Accountant having qualified with PWC in London and has an MBA from Durham University and INSEAD.
This person is not in any offices
Revitope Oncology
Revitope Oncology is a biotech company leveraging biological insights and protein engineering to develop a new class of cancer immunotherapies powered for precision.